Hitchwood Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-145,000
Closed -$13.1M 51
2019
Q3
$13.1M Sell
145,000
-45,000
-24% -$5.13M 0.6% 39
2019
Q2
$22.4M Sell
190,000
-35,000
-16% -$3.53M 0.38% 46
2019
Q1
$19.5M Buy
+225,000
New +$19.2M 0.28% 44
2018
Q4
Sell
-725,000
Closed -$57.2M 35
2018
Q3
$57.2M Buy
725,000
+425,000
+142% +$27.7M 0.81% 22
2018
Q2
$17.9M Buy
300,000
+131,635
+78% +$7.08M 0.56% 33
2018
Q1
$6.79M Buy
+168,365
New +$8.21M 0.33% 36

Other funds holding EXAS

Hitchwood Capital Management's EXAS Position: Q4 2019 in Review

Hitchwood Capital Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 145,000 shares — an estimated $13.1M sold.

Hitchwood Capital Management first reported a position in EXAS in Q1 2018 and held it in 6 quarters. The position peaked at $57.2M in Q3 2018. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Hitchwood Capital Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
  • Hitchwood Capital Management sold 145,000 Exact Sciences shares in Q4 2019, an estimated $13.1M.
  • Hitchwood Capital Management first reported a position in Exact Sciences in Q1 2018 and held it in 6 quarters.
  • Hitchwood Capital Management's Exact Sciences position peaked at $57.2M in Q3 2018.
  • 527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Hitchwood Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.